What is the market cap difference between LLY and MRK?

LLY has a market cap of $896.1B and MRK has a market cap of $275.1B. LLY has a 3.3x larger market capitalization than MRK

LLY vs MRK Stock Comparison

Compare Eli Lilly and Company (LLY) and Merck & Company, Inc. (MRK) side by side. View price, valuation, dividends, and financial metrics.

Eli Lilly and Company

$1,004.92-0.18%

Healthcare / Drug Manufacturers - General · $896.1B market cap

Merck & Company, Inc.

$111.38-1.79%

Healthcare / Drug Manufacturers - General · $275.1B market cap

Both LLY and MRK operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

LLY has a 3.3x larger market capitalization than MRK.

MRK trades at a lower P/E ratio (31.4x) compared to LLY (35.7x), suggesting MRK may be more attractively valued relative to its earnings.

MRK offers a higher dividend yield (3.05%) vs LLY (0.69%), making it more attractive for income investors.

Looking at profitability, LLY has a profit margin of 35.0% while MRK's is 13.6%. LLY converts more of its revenue into profit.

In terms of growth, LLY has revenue growth of 55.5% versus 4.9% for MRK. LLY is growing its top line faster.

Which is a better investment, LLY or MRK?: Both stocks have different strengths. Eli Lilly and Company (LLY) trades at $1,004.92 with a $896.1B market cap, while Merck & Company, Inc. (MRK) trades at $111.38 with a $275.1B market cap. MRK trades at a lower P/E ratio (31.4x) compared to LLY (35.7x), suggesting MRK may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are LLY and MRK in the same sector?: Both LLY and MRK operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do LLY and MRK pay dividends?: MRK offers a higher dividend yield (3.05%) vs LLY (0.69%), making it more attractive for income investors.